Search for Clinical Trial Results
Drug Eruptions - 23 Studies Found
Status | Study |
Recruiting |
Study Name: Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study Condition: Toxic Epidermal Necrolysis Date: 2016-06-06 Interventions:
|
Recruiting |
Study Name: Comparison Between Corticosteroid and Topical Steroids in the DRESS Condition: Drug Rash With Eosinophilia and Systemic Symptoms Date: 2013-09-17 Interventions:
|
Completed |
Study Name: Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment Condition: Beta-lactam Allergy Date: 2011-11-20 Interventions: Drug: Beta-lactam oral challenge Oral daily dose, according to patient's weight, of amoxicillin or other |
Withdrawn |
Study Name: Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream Condition: Medication Reaction Date: 2011-05-05 Interventions: Drug: Tretinoin tretinoin 0.025% cream |
Recruiting |
Study Name: MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY Condition: Dermatitis, Adverse Drug Reaction Date: 2014-01-14 Interventions:
|
Recruiting |
Study Name: The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia Condition: Palmar-Plantar Erythrodysesthesia Date: 2015-12-05 Interventions:
|
Recruiting |
Study Name: Testing the Effectiveness of Henna on Managing PPE Condition: Palmar-plantar Erythrodysesthesia (PPE) Date: 2012-12-14 Interventions:
|
Recruiting |
Study Name: Prevention of Capecitabine Induced Hand and Foot Syndrome Condition: Cancer Date: 2011-02-07 Interventions: Device: socks containing copper-oxide fibers The patients will use a sock which contains copper fibers. |
Completed |
Study Name: Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil Condition:
Date: 2010-10-08 Interventions: Drug: sildenafil citrate Subjects will be given 2 types of topical creams, one containing 1% sildenafil |
Terminated |
Study Name: Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer Condition:
|